AI-Powered Virtual Screening
Rapidly evaluates millions of compounds against biological targets using deep learning and foundation models. Reduces dependency on traditional high-throughput assays by delivering high-confidence predictions in silico
About Our Platform
Reimagining the Science of Discovery
BioWave.AI™ brings together AI-driven automation, predictive modeling, and integrated biological datasets to reinvent how biopharma companies discover and design therapeutic candidates. With capabilities spanning virtual drug screening, novel compound generation, and phenotypic discovery, the platform delivers deeper insights, shorter timelines, and a higher likelihood of clinical success within a secure, scalable framework.
Why Use BioWave.AI™?
From Sunk Costs to Strategic Recovery
BioWave.AI™ transforms traditional drug discovery by integrating AI-driven screening, generative molecule design, and phenotypic analysis within a single, intelligent platform. It enables faster identification of therapeutic candidates, uncovers novel mechanisms through biological pattern recognition, and reduces costly trial-and-error cycles. With its ability to learn from complex datasets and optimize every stage of discovery, BioWave.AI™ drives smarter, faster, and more successful R&D outcomes
Key Features & Capabilities
Phenotypic Discovery & Mechanism Insights
Analyzes cell-based assay data and phenotypic responses to identify hidden therapeutic pathways. Reveals new indications and repurposing opportunities by linking molecular behavior to clinical outcomes.
Unified Biological Intelligence Layer
Integrates genomics, proteomics, and transcriptomics data into cohesive knowledge graphs. Enables systems-level understanding of disease biology and drug interactions.
Generative Molecule Design
Creates novel small molecules, proteins, and biologics optimized for specific therapeutic goals. Expands chemical space beyond existing libraries using advanced generative AI models.
Predictive Safety & Pharmacokinetics
Assesses toxicity, ADMET properties, and off-target effects early in development using trained predictive models. Minimizes late-stage failures and improves candidate quality from the start.
Workflow Automation & Continuous Learning
Automates data processing, experiment planning, and model refinement across the discovery pipeline. Continuously learns from new outcomes to improve predictions and accelerate decision-making.
Build the future of
biology with us
Contact Us
Stay Ahead with
ThinkBio.Ai®
Subscribe to our newsletter to receive the latest updates on products, sustainability efforts and services.